Trial intelligence / Profile preview

LOCARE: Esophageal Washout in Esophageal Resection

NCT02676791Completed

Sponsor
Technische Universität Dresden
Start
Feb 2016
Primary completion
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of povidone-iodine in esophageal cancer, sponsored by Technische Universität Dresden. Primary endpoint: Local carcinoma recurrence at 36 months. Started Feb 2016; status: completed.

02

Drugs

povidone-iodine
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT02676791.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02676791.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call